February 27, 2017
For nearly seven years, RxRights has been fighting to promote and protect access to safe and affordable medicine. Regrettably, we're going to be forced to close our doors at the end of the month. It pains us to announce this closure—especially as the drug pricing issue is gaining traction in the media and with … Continue to Article-->
February 2, 2017
We’ve been working with some allies concerned with the high cost of insulin. Through these connections, we found out about a class action lawsuit focused on insulin prices. The lawsuit, brought by a firm called Hagens Berman, alleges that the top three insulin manufacturers, Sanofi, Novo Nordisk and Eli Lilly, have … Continue to Article-->
February 1, 2017
Our lead organizer, Lee Graczyk, was part of a panel in Minneapolis last week organized by Senators Amy Klobuchar (D-MN) and Tammy Baldwin (D-WI) regarding drug prices. The panel discussed methods of lowering prescription drug prices related to the senators’ new legislation. In January, they introduced S.41, the … Continue to Article-->
January 13, 2017
The process of dismantling the Affordable Care Act began in earnest earlier this week, as the Senate held a “vote-a-rama,” before passing the budget resolution ultimately designed to repeal the bill. During vote-a-rama, debate is limited but Senators are able to offer an unlimited number of amendments. Senators … Continue to Article-->
January 4, 2017
Pharmaceutical companies have significant power and influence over our health – but this influence isn’t always positive. In order to push their products, pharmaceutical companies have paid doctors across a variety of fields of medicine to prescribe their drugs. The Law Firm created this infographic to highlight big … Continue to Article-->
Consumers should follow ...
We regularly hear ...